Commonly patients undergoing surgery for fibroids are advised on a risk of underlying malignancy of 17 in 1,000,000, based on the rate of uterine malignancies in the general population.
Given the morbidity associated with hysterectomy, less-invasive options for treating symptomatic uterine fibroids are appealing. In this manufacturer-sponsored, prospective, multicenter trial ...
China has completed a remote single-arm robotic surgery for a patient in the country's Xizang Autonomous Region, marking a major breakthrough in combining medical technology with information ...
It has been recommended for use as a longer-term treatment of six months or more and is not intended for people who need short-term treatment, for example, before planned uterine fibroid surgery ...